[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.65.227. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 1980

Conversion of MHPG to Vanillylmandelic AcidImplications for the Importance of Urinary MHPG

Author Affiliations

From Baker Medical Research Institute, Prahran, Victoria, Australia (Dr Blombery); and the Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Md (Drs Kopin, Markey, and Ebert and Ms Gordon). Dr Blombery was a Guest Worker at the Laboratory of Clinical Science from April 24, 1977 to Dec 17, 1979; he was supported by the Royal Australian College of Physicians and Surgeons from April 24, 1977 to May 8, 1979, at which time he received a Fogarty International Fellowship.

Arch Gen Psychiatry. 1980;37(10):1095-1098. doi:10.1001/archpsyc.1980.01780230013001
Abstract

• Deuterium-labelled 4-hydroxy-3-methoxyphenylglycol (MHPG), when administered intravenously, is rapidly converted to 4-hydroxy-3-methoxymandelic acid (or vanillylmandelic acid [VMA]) or conjugates of MHPG. Since over half of either racemic D,L-MHPG or the natural D-MHPG is converted to VMA and since about half of urinary VMA is derived from MHPG, estimates of the proportion of urinary MHPG derived from the brain must be revised. The results indicate that only about one fifth of urinary MHPG is derived from the brain, and clearly urinary MHPG cannot be used as a valid index of brain norepinephrine metabolism. While these observations do not alter the value of urinary MHPG as a predictor of therapeutic response or in subclassifying affective disorders, it is clear that new research questions must be formulated and appropriate investigations completed before the relationship of urinary MHPG to affective disorders is understood.

×